9 Anti-Emetics Flashcards

1
Q

Following this lecture you should be able to …

A

Demonstrate an understanding of the physiological basis for emesis from signal detection to the central processing of information.

Describe the key molecular aspects of signal sensing in the central nervous system with specific reference to receptor subtypes.

Demonstrate an understanding of the applied pharmacology for emesis and the relationship to signal recognition and transduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Identified Applied Pharmacology

A

To Review:

Histamine H1-receptor antagonists (e.g. cylizine, cinnarizine, promethazine )

Serotonin or 5-HT3 receptor antagonists (e.g. ondansetron )

Muscarinic (mACh) receptor antagonists (e.g hyoscine, scopolaimine)

D2-receptor antagonists (e.g. phenothiazines, chloropromazine, perphenazine, metoclopramide, domperidone)

Cannabinoids (e.g. nabilone)

Neurokinin-1 antagonist (e.g. aprepitant)

Corticosteroids & Dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Emesis – Overview

A

Emesis
Physical event; forceful evacuation of gastric contents through mouth; A protective physiological mechanism in response to something harmful being ingested

Stages: Feeling of nausea Retching Vomiting
Emetic – agent which causes vomiting Anti-emetic – agent which prevents vomiting
Occurs in motion sickness, and vestibular disorders…
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Emesis – Overview

A

Accompanies Numerous Disease States
e.g. migraine, bacterial and viral infections, etc

Accompanies Changes in Physiological Status
e.g. pregnancy; motion sickness

An Unwanted Side Effect of Clinically-Used Drugs

Anti-cancer agents: Chemotherapy-Induced
Nausea & Vomiting (CINV)

Anaesthetics: Post Operative Nausea & vomiting (PONV)

Opioids

70- 80% of cancer patients treated with anti-neoplastic agents experience emesis; 10-44% have anticipatory emesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Integrated Physiology of Emesis

A

The Vomiting Reflex is regulated by the CNS (medulla)

The mechanism of emesis is a complex process dependent on multiple biological, chemical, and neural pathways.

Emesis is controlled and centralized within the brainstem in a neural network on the dorsal surface of the medulla oblongata.

This region is referred to as the “brainstem emetic (vomiting) control center” or dorsal vagal complex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Integrated Physiology of Emesis

A

There are three major inputs to the dorsal vagal complex which cause nausea and vomiting:

The Chemoreceptor Trigger Zone (located in the dorsal vagal complex),

The Vagal Pathway

The Vestibular Pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Integrated Physiology of Emesis

A

The rational therapeutic approach to the pathophysiology of emesis (inc CINV) includes blockade of the neurotransmitters involved in the triggering the response…

Blockade of the neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Signal Integration and Drugs

A

Endogenous mediators of emesis - Antagonists i.e. anti-emetics

Serotonin - 5HT3
ACh - M
Dopamine - D2
Substance P - NK1
Histamine - H1
Enkephalin - δ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

General Antiemetic Drugs

A

Choice of drug will be based upon the stimulus causing nausea and vomiting which determines which receptors are activated

Several classes of drugs are effective and available

Used for specific conditions, but there is overlap

Many histamine, muscarinic & serotonin receptor antagonists exhibit clinically useful activity

Different classes of anti-emetics have different side effect profiles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anti-Emetic Histamine Receptor Antagonists

A
H1 Antagonists / Antihistamines
Anti-Emetics
Histamine Antagonists
	Motion Sickness
	Vestibular disease
	GI irritants
Anti-Emetics
Histamine Antagonists
cyclizine
promethazine
cinnarizine

Cyclizine - motion sickness
Cinnarizine - motion sickness, vestibular disorders (e.g. Meniére´s disease, vertigo)
Promethazine - severe morning sickness of pregnancy

Of limited use against substances that act directly on CTZ

Side effects: Drowsiness and sedation; but these do contribute to efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Histamine Receptor Agonists

A

H3 Agonists
Betahistine hydrochloride / anti-vertigo drug Serc®.

Mode of action:
Activates H-receptors on blood vessels in the inner ear
→ local vasodilation
→ increased permeability
→ reverses the underlying problem of endolymphatic hydrops

Side-effects: gastro-intestinal disturbances; headache, rashes, pruritus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti-Emetic Muscarinic Receptor Antagonists

A

Good “general purpose” antiemetics

Hyoscine, Scopolaimine

  • non-selective antagonists
  • motion sickness (drug of choice)
  • oral and / or transdermal patch application

Side-effects:

  • dry mouth, blurred vision,
  • less sedative actions than antihistamines

Anti-Emetics Acetylcholine Antagonists
Motion Sickness
hyoscine
scopolaimine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anti-Emetic Dopamine Receptor Antagonists

A

D2 receptors have a strong representation in the in CTZ

D2 Antagonists have a powerful anti-emetic action, and will antagonise muscarinic and histamine receptors too…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anti-Emetic Dopamine Receptor Antagonists

A

D2 receptor antagonist

Phenothiazines

Severe morning sickness of pregnancy
Administered orally, i.v. or suppository
Inexpensive

Side-effects: sedative, hypotension,
dystonia (especially children), dyskinesia

Prochlorpromazine - tablet or intramuscular injection.
Perphenazine – tablet, & trifluoperazine (tablet) are less sedative than chloropromazine (tablet or deep intramuscular injection)

Dopamine
Antagonists
	Ureamia
	Opioid-induced emesis
	CINV
	GI disorders
	Viral Gasteroent-eritis
phenothiazines
perphenazine
prochloropromazine
metoclopramide domperidone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anti-Emetic Dopamine Receptor Antagonists

A

D2 receptor antagonist
Metoclopramide

Penetrates blood brain barrier
Acts on GIT; increasing GI motility
Oral administration/injection (i.m./i/v.)

Side-effects: movement disorders (esp. children), fatigue, motor restlessness, spasmodic torticollis, occulogyric crises, menstruation disorders (via effect on prolactin release), Rare Reactions; QT prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anti-Emetic Dopamine Receptor Antagonists

A

D2 receptor antagonist
Domperidone (Motilium, Motillium)

Does not penetrate BBB; has reduced central effectiveness, but fewer side effects

Used for migraine & cytotoxic therapy-induce emesis; emesis due to emergency hormonal contraception

Oral administration/i.v./suppositories

17
Q

Anti-Emetic Serotonin Receptor Antagonists

A

Ondansetron

Drug of choice for CINV and PONV
Oral, suppositories, i.v. or intramuscular administration

Side-effects: gastro-intestinal disturbances; headache (not common)

Granisetron (Oral, i.v.), palonosetron (i.v.), tropisetron (Oral, i.v.)

Serotonin Antagonists

Chemotherapy (CINV)
Anesthetics (PONV)
Radiation Induced Vomiting ondansetron
18
Q

Anti-Emetic NK1R Antagonists

A

Neurokinin-1 antagonist
Active in late phase emesis with cytotoxic drugs

Aprepitant
Substance P antagonist
Used for CINV and PONV
Oral / i.v. admin

19
Q

Anti-Emetic NK1R Antagonists

A

Neurokinin-1 antagonist
Active in late phase emesis with cytotoxic drugs

Aprepitant
Substance P antagonist
Used for CINV and PONV
Oral / i.v. admin

Side Effects: fatigue, listlessness, constipation / diarrhea, loss of appetite, hiccups Rare Side Effects: dizziness, ringing in the ears, hiccups, dyspepsia, diarrhoea, constipation, anorexia; asthenia, headache..

Fosaprepitant (a prodrug of aprepitant), Casopitant, Maropitant (motion sickness)

20
Q

Anti-Emetic Action of Cannabinoids

A

Nabilone (Cesamet)
Mimetic of the main chemical component of cannabis (HTC)
Valuable in the treatment of CINV ; FDA approval in 1985, marketed 11 years later
Thought to act via opioid receptors in CTZ
Adjunct therapy for chronic pain management

Nabilone (Cesamet)
Mimetic of the main chemical component of cannabis (HTC)
Valuable in the treatment of CINV ; FDA approval in 1985, marketed 11 years later
Thought to act via opioid receptors in CTZ
Adjunct therapy for chronic pain management

Oral Administration
Side effects: drowsiness, dizziness, dry mouth, mood changes, postural hypotension Rare Side Effects:, hallucinations, psychotic reactions

Other cannabinoid mimetics: Marinol (Dronabinol)

21
Q

Corticosteroids & Antiemetics

A

Corticosteroids
Dexamethasone
‡ vomiting caused by cytotoxics (chemotherapy)
‡ mechanism of action not fully understood
‡ used in combination with D2 or 5HT3 antagonists → improved actions

22
Q

Summary of Key Anti-Emetics

A

Morning sickness - Promethazine / phenothiazines

Motion sickness - Hyoscine / Promethazine / cyclizine

PONV - Phenothazines / metoclopramide

CINV - Ondansetron / phenothiazines

Opioids - Haloperidol / metoclopramide

Gastroenteritis - Metoclopramide

Anticipatory Emesis - Benzodiazepines

23
Q

Therapeutic Uses of Emetics

A

Used for
Poisonous substance ingested
Drug overdose
Alcohol intoxication

Not for
Ingestion of corrosive substances
CNS stimulant, morphine overdose
Kerosene poisoning

Patient must be fully conscious

24
Q

Therapeutic Uses of Emetics

A

Syrup of ipecac. (ipecacuanha)
Comprises two alkaloids emetine & cepheline
Oral administration, works within ~15mins
Irritates gastric mucosa and activates CTZ directly

Apomorphine
Directly stimulate CTZ & VC
Administered IM or SC and acts within 5-10mins

Activated charcoal
Most commonly used; adsorbant – binds toxins

25
Q

Following this lecture you should be able to…

A

Demonstrate an understanding of the physiological basis for emesis from signal detection to the central processing of information.

Describe the key molecular aspects of signal sensing in the central nervous system with specific reference to receptor subtypes.

Demonstrate an understanding of the applied pharmacology for emesis and the relationship to signal recognition and transduction